DF/HCC Cancer Metabolism Symposium
Wednesday, April 16 at 1:00pm to 5:00pm
Dana-Farber Cancer Institute, Yawkey 306/307
The Cancer Cell Biology Program* and the DF/HCC Alliance for Developing Effective Targeted Therapies** is holding a joint symposium relating to metabolism and cancer. The goal of this timely symposium is to bring together local scientists and clinicians who focus on basic insight into cancer cell metabolism, translational efforts to target the metabolic dependencies of cancer cells, and epidemiological studies linking metabolism and cancer risk.
Brian Wolpin (DFCI), “Altered systemic metabolism and pancreatic cancer pathogenesis”
Matt Vander Heiden (MIT), “The role of altered metabolism in supporting tumor progression”
Lorelei Mucci (HSPH), “Metabolic consequences of obesity on cancer risk and mortality”
Brendan Manning (HSPH), “Linking oncogenic signaling to cancer metabolism through mTOR”
Bruce Spiegelman (DFCI/HMS), “Brown Fat and Cancer Cachexia-When Friends Go Bad”
Andrea McClatchey* (MGH), Karen Cichowski** (BWH), Alex Toker (BIDMC)
A wine and cheese reception will follow the symposium.
Organized by: DF/HCC Alliance for Developing Effective Targeted Therapies and the Cancer Cell Biology Program
No recent activity